CoChat

Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity

Cassar, Samantha, Teede, Helena J., Harrison, Cheryce L., Joham, Anju E., Moran, Lisa J., Stepto, Nigel K. · 2015 · Clinical Endocrinology
Cited by 60

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Summary: Objective: Polycystic ovary syndrome (PCOS) is a common endocrine disorder associated with metabolic complications. Metabolic biomarkers with roles in obesity, glycaemic control and lipid metabolism are potentially relevant in PCOS. The aim was to investigate metabolic biomarkers in lean and overweight women with and without PCOS and to determine whether any biomarker was able to predict insulin resistance in PCOS. Design: Cross‐sectional study. Patients: Eighty‐four women (22 overweight and 22 lean women with PCOS, 18 overweight and 22 lean women without PCOS) were recruited from the community and categorized based on PCOS and BMI status. Measurements: Primary outcomes were metabolic biomarkers [ghrelin, resistin, visfatin, glucagon‐like peptide‐1 (GLP‐1), leptin, plasminogen activator inhibitor ‐1 (PAI‐1), glucose‐dependent insulinotropic polypeptide (GIP) and C‐Peptide] measured using the Bio‐Plex Pro Diabetes assay and insulin sensitivity as assessed by glucose infusion rate on euglycaemic–hyperinsulinaemic clamp. Results: The biomarkers C‐peptide, leptin, ghrelin and visfatin were different between overweight and lean women, irrespective of PCOS status. The concentration of circulating biomarkers did not differ between women with PCOS diagnosed by the Rotterdam criteria or National Institute of Health criteria. PAI‐1 was the only biomarker that significantly predicted insulin resistance in both control women (P = 0·04) and women with PCOS (P = 0·01). Conclusions: Biomarkers associated with metabolic diseases appear more strongly associated with obesity rather than PCOS status. PAI‐1 may also be a novel independent biomarker and predictor of insulin resistance in women with and without PCOS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cen.12619

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 60

Metadata

Authors
Cassar, S., Teede, H. J., Harrison, C. L., Joham, A. E., Moran, L. J., & Stepto, N. K.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2014-11-07
Volume
83
Issue
1
Pages
50-58
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W1981270543
Cited by
60
References
18
FWCI
6.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity. https://app.cochat.ai/papers/10.1111/cen.12619
The paper
Cassar, S., Teede, H. J., Harrison, C. L., Joham, A. E., Moran, L. J., & Stepto, N. K. (2015). Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity. Clinical Endocrinology. https://doi.org/10.1111/cen.12619

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.